Corporate Profile

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California.

Recent Press Releases

November 16, 2016 - 5:01 p.m.
Gilead Sciences Announces Promotion of James R. Meyers to Executive Vice President, Worldwide Commercial OperationsPrinter Friendly Version 
November 16, 2016 - 4:16 p.m.
Gilead Announces Top-Line Results From Two Phase 3 Studies Evaluating Momelotinib for Patients With MyelofibrosisPrinter Friendly Version 

Upcoming Events

Saturday, December 3, 2016 through Tuesday, December 6, 2016
American Society of Hematology (ASH) 58th Annual Meeting
LocationSan Diego, CA

Most Viewed Links

Updated 12/02/16
1.SEC Filings
3.Annual Reports
4.Stock Information
5.Fundamentals - Snapshot
* Data collected 11/24/16 - 12/01/16

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
NASDAQ (US Dollar)
 Stock is Down 0.16 (0.22%)
Data as of 12/02/16 2:48 p.m. ET
Minimum 20 minute delay
Refresh Quote
Recent Webcasts
Credit Suisse 25th Annual Healthcare Conference

November 07, 2016 8:00 a.m. MT
Third Quarter 2016 Gilead Sciences Earnings Conference Call

November 01, 2016 4:30 p.m. ET